FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Substantial Rates of Inappropriate TIRF Use Seen: Study

Researchers say inappropriate prescribing of transmucosal immediate release fentanyl products occurred despite a REMS intended to ensure appropriate p...

Medical Devices

Medtronic Gains Breakthrough Status for Insulin Pump

FDA grants Medtronic a breakthrough device designation for its investigational Personalized Closed Loop insulin pump system.

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that include Mark Berman and Datascope.

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 2/15/2019.

FDA General

Product Approval Summaries

FDA Review posts product approval summaries for the week ending 2/15/2019

Federal Register

Comments Reopened on Real World Evidence Program

Federal Register notice: FDA reopens the comment period on a 12/7/2018 notice entitled Framework for a Real-World Evidence Program; Availability.

Federal Register

Panel to Discuss Breast Implant Benefit/Risk

Federal Register notice: FDA announces a 3/25-26 General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee meeting that will...

Federal Register

Established Conditions Pilot Program for Drugs

Federal Register notice: CDER provides an opportunity for a limited number of applicants to participate in an Established Conditions Pilot Program.

Medical Devices

Device Makers to Get Nonbinding Feedback on Inspection Findings

FDA issues a draft guidance on Nonbinding Feedback After Certain FDA Inspections of Device Establishments, which proposes a process where device compa...

Human Drugs

Priority Review for Merck Keytruda sBLA

FDA accepts for priority review a Merck supplemental BLA for Keytruda for use in combination with Inlyta (axitinib), a tyrosine kinase inhibitor, for ...